A detailed history of Delta Financial Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Delta Financial Advisors LLC holds 638 shares of VRTX stock, worth $253,458. This represents 0.11% of its overall portfolio holdings.

Number of Shares
638
Previous 618 3.24%
Holding current value
$253,458
Previous $289,000 2.42%
% of portfolio
0.11%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$460.0 - $505.78 $9,200 - $10,115
20 Added 3.24%
638 $296,000
Q1 2024

May 07, 2024

BUY
$407.69 - $446.08 $6,115 - $6,691
15 Added 2.49%
618 $258,000
Q2 2023

Aug 03, 2023

BUY
$314.42 - $351.91 $189,595 - $212,201
603 New
603 $212,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $102B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Delta Financial Advisors LLC Portfolio

Follow Delta Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Financial Advisors LLC with notifications on news.